Skip to main content

Table 6 Results of Box–Behnken designs

From: Formulation and optimization of polymeric agglomerates of Bosentan monohydrate by crystallo-co-agglomeration technique

Batch

Talc (%)

PEG 6000(%)

SPEED (RPM)

Y1 (particle size) µm

Y2 (angle of repose) degree

Y3 (drug content) %

BOS 1

2.00

3.50

1000

06.45 ± 0.028

36.33 ± 0.473

64.28 ± 0.509

BOS 2

2.00

5.00

800

09.56 ± 2.107

32.67 ± 0.233

74.55 ± 0.318

BOS 3

2.00

3.50

600

09.86 ± 0.098

32.88 ± 0.848

89.73 ± 0.190

BOS 4

0.50

2.00

800

06.10 ± 0.212

35.33 ± 0.473

62.05 ± 0.671

BOS 5

1.25

5.00

600

13.57 ± 0.219

30.00 ± 0.707

93.89 ± 0.077

BOS 6

0.50

5.00

800

06.24 ± 0.077

36.67 ± 0.233

68.3 ± 0.494

BOS 7

0.50

3.50

1000

05.95 ± 0.035

37.67 ± 0.233

51.78 ± 0.466

BOS 8

0.50

3.50

600

07.26 ± 0.169

34.33 ± 0.473

68.3 ± 0.486

BOS 9

1.25

2.00

600

12.67 ± 0.233

31.00 ± 0.707

85.34 ± 0.601

BOS 10

2.00

2.00

800

07.15 ± 0.176

34.67 ± 0.233

85.34 ± 0.311

BOS 11

1.25

2.00

1000

06.79 ± 0.148

36.95 ± 0.035

69.15 ± 0.622

BOS 12

1.25

3.50

800

09.15 ± 0.247

32.33 ± 0.473

72.56 ± 0.155

BOS 13

1.25

3.50

1000

07.176 ± 0.087

34 ± 0.707

51.12 ± 0.494

  1. Mean ± SD = 3, n = 3